Aussie scientists, ethicists blast human cloning news
08 April, 2002 by Tanya HollisAustralian scientists and ethicists have expressed dismay and disbelief at reports a woman is eight weeks pregnant with the world's first human clone.
Bioinformatics: Lights on, no one home?
05 April, 2002 by Iain ScottPilots, not planes, are needed to get Australia's nascent bioinformatics industry off the ground, according to one of the authors of a new report.
Patents shouldn't apply to gene sequences: Affymetrix
05 April, 2002 by Melissa TrudingerUS company Affymetrix has told a government panel that patents should not be applied to gene sequences.
Bio gold rush could pay off for enterprise IT
04 April, 2002 by Elizabeth HeichlerLike most of us, IT managers at major retailing or banking companies probably find the current revolution in life sciences research compelling because of its promise to disarm hereditary diseases or cancers. But they may not realise that they also have a professional self-interest in computationally driven work on genetics, proteins, and pharmaceuticals.
Genaissance announces initial STRENGTH findings
02 April, 2002 by Malorye BrancaResearchers at Genaissance Pharmaceuticals have found "statistically significant" associations between genetic markers and certain patient responses to cholesterol-lowering drugs. Such associations, or links, could be used to develop pharmacogenomic tests that would help physicians determine the best drug for a particular patient.
Major bio-IT shake-up at CSIRO
27 March, 2002 by Pete YoungCSIRO's major bioinformatics group is being reorganised and consolidated in a plan that could involve spinning off part of it as commercial operation.
Biotech's golden child is still in utero
26 March, 2002 by Pete YoungLike a gold-plated corkscrew, bioinformatics is all about unplugging the data bottleneck that clogs drug R&D pipelines.
Shimadzu to develop DNA sequencer with GenoMems IP
21 March, 2002 by Martyn WilliamsShimadzu Biotech, the bio-IT arm of Japan's Shimadzu Corp, and Boston-based start-up GenoMems have signed a deal under which the two companies plan to develop and commercialise a fast DNA sequencer.
Gene researcher wins award
20 March, 2002 by Melissa TrudingerKaren Lower has won Adelaide's Women's and Children's Hospital's annual Young Investigator of the Year Award for her work identifying the genetic cause of Borjeson-Forssman-Lehmann Syndrome (BFLS), a severe form of intellectual disability.
Novel proteins may target cystic fibrosis
19 March, 2002 by Daniella GoldbergSydney company Proteome Systems has teamed up with US group Cystic Fibrosis Foundation Therapeutics to find drug targets to combat the disease.
Capellas: biotech needs computing collaboration
19 March, 2002 by Nancy WeilBiotechnology will reach its potential only if companies involved in related markets collaborate and focus on standards-based technologies rather than proprietary work, said Michael Capellas, chairman and chief executive officer of Compaq, on Thursday.
Watch this island: Taiwan pushes into biotech
15 March, 2002 by Sumner LemonHsinchu is not just any Taiwanese city, however. For many years, this island of 22 million people has thrived as a manufacturing base for computing hardware, and Hsinchu, with its massive semiconductor factories, has been its high-tech heart.
Lander sees life sciences revolution
14 March, 2002 by Elizabeth HeichlerEric Lander, one of the world's leading scientists on the forefront of genome research, kicked off the BioITWorld conference in Boston on Wednesday with an overview of the dramatic progress made in biology in the past few years as a result of the sequencing of the human genome, and how this new information is being applied to investigate and fight diseases.
IT meets biology in donor program
14 March, 2002 by Mary BrandelPaul Zyla, director of information systems at the non-profit National Marrow Donor Program (NMDP) in Minneapolis, and Martin Maiers, manager of bioinformatics and research systems, discuss how IT meets medicine in an effort to save lives.
Queensland splurges on supercomputer
14 March, 2002 by Pete YoungA $4 million supercomputer is the Queensland government's latest addition to its already impressive investment in the state's biotech infrastructure assets.
